ストックスクリーナーアプリを入手
133.27
3.40%
-4.9582
前日終値:
$138.23
開ける：
$140.85
24時間の取引高:
343.25K
Relative Volume:
0.40
時価総額：
$6.50B
収益：
-
当期純損益:
$-192.89M
株価収益率:
-34.19
EPS:
-3.8976
ネットキャッシュフロー:
$-172.97M
1週間 パフォーマンス:
+1.96%
1か月 パフォーマンス:
+10.32%
6か月 パフォーマンス:
+33.06%
1年 パフォーマンス:
+1,179%
1日の値動き範囲:
$132.87
$140.85
1週間の範囲:
$130.46
$142.81
52週間の値動き範囲:
$10.26
$151.02
Celcuity Inc Stock (CELC) Company Profile
Compare CELC vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
133.33 | 6.74B | 0 | -192.89M | -172.97M | -3.8976 |
VRTX
Vertex Pharmaceuticals Inc
|
437.04 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
637.07 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
804.14 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.00 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
153.80 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-27 | 開始されました | Citizens | Mkt Outperform |
| 2025-12-12 | 開始されました | Wells Fargo | Overweight |
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-11-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | 開始されました | Guggenheim | Buy |
| 2025-07-01 | 再開されました | Stifel | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-02-22 | 開始されました | Stifel | Buy |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-07 | 開始されました | Jefferies | Buy |
| 2021-07-29 | 開始されました | Cowen | Outperform |
| 2021-07-27 | 開始されました | Needham | Buy |
| 2021-01-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-11 | 再開されました | Craig Hallum | Buy |
| 2018-11-20 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Celcuity Inc (CELC) 最新ニュース
Why is Avoro Capital Advisors Making a Big Bet on Celcuity (CELC) - Kavout
Celcuity Inc. Advances SEC Compliance and Capital Markets Goals - Faegre Drinker Biddle & Reath LLP
Price-Driven Insight from (CELC) for Rule-Based Strategy - Stock Traders Daily
Celcuity Inc. Files Amendment No. 1 to Form 8-K/A with SEC for February 2026 Event - Minichart
Celcuity Inc. Appoints Charles Romp to Compensation Committee and Nominating and Corporate Governance Committee, Effective May 14, 2026 - marketscreener.com
Celcuity’s Gedatolisib Shines Amid Mounting Cash Burn - TipRanks
Celcuity Is Maintained at Buy by HC Wainwright & Co. - Moomoo
H.C. Wainwright Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $185 - Moomoo
Celcuity Shareholders Approve New 2026 Equity Incentive Plans - The Globe and Mail
Celcuity: Approaching An Inflection Point With Gedatolisib (NASDAQ:CELC) - Seeking Alpha
CELC Maintained by HC Wainwright & Co. -- Price Target Raised to $185 - GuruFocus
Citizens reiterates Celcuity stock rating ahead of July approval By Investing.com - Investing.com Australia
Celcuity (CELC) price target increased by 20.06% to 159.86 - MSN
Citizens reiterates Celcuity stock rating ahead of July approval - Investing.com UK
Celcuity stock price target raised to $185 by H.C. Wainwright - Investing.com UK
Celcuity stock price target raised to $185 by H.C. Wainwright By Investing.com - Investing.com Australia
UBS Group AG Reduces Stock Position in Celcuity, Inc. $CELC - MarketBeat
Celcuity Price Target Raised to $185.00/Share From $165.00 by HC Wainwright & Co. - Moomoo
Why Celcuity (CELC) Is Up 5.1% After VIKTORIA-1 Success And Pipeline ExpansionAnd What's Next - Sahm
Celcuity outlines VIKTORIA-2 expansion while targeting July 17 FDA decision for gedatolisib - MSN
LifeSci Capital Maintains Celcuity(CELC.US) With Buy Rating, Maintains Target Price $165 - Moomoo
Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst - Sahm
Celcuity (CELC) Gets a Buy from Stifel Nicolaus - The Globe and Mail
Celcuity Inc. (NASDAQ:CELC) Q1 2026 Earnings Call Transcript - Insider Monkey
Assessing Celcuity (CELC) Valuation After Positive VIKTORIA 1 Data And Upcoming FDA Decision - Yahoo Finance
Celcuity Q1 earnings call highlights - MSN
Celcuity’s Earnings Call: Strong Data, Rising Cash Burn - TipRanks
Celcuity (NASDAQ:CELC) Posts Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
Stifel raises Celcuity stock price target on trial expansion potential - Investing.com UK
Celcuity's cancer drug expansion could ignite massive new market opportunity: Analyst - MSN
Analysts Are Bullish on Top Healthcare Stocks: Celcuity (CELC), Rubicon Organics (ROMJF) - The Globe and Mail
What's Going On With Celcuity Stock Friday?Celcuity (NASDAQ:CELC) - Benzinga
Stifel raises Celcuity stock price target on trial expansion potential By Investing.com - Investing.com Australia
Stifel Maintains Celcuity(CELC.US) With Buy Rating, Raises Target Price to $175 - Moomoo
A Quick Look at Today's Ratings for Celcuity(CELC.US), With a Forecast Between $157 to $183 - Moomoo
Celcuity Inc. Stock 12‑Month Price Target Raised to $167.18, Implies 24% Upside - TradingView
Celcuity Inc. Stock 12‑Month Price Target Raised to $164, Implies 22% Upside - TradingView
Celcuity Inc. Stock 12‑Month Price Target Raised to $159, Implies 18% Upside - TradingView
Celcuity Q1 2026 Earnings Call Transcript - MarketBeat
Celcuity Q1 Earnings Call Highlights - sharewise.com
CELC: Positive phase III data and commercial launch readiness mark a pivotal Q1 2026 - TradingView
Celcuity (CELC) Q1 2026 Earnings Transcript - The Globe and Mail
Earnings call transcript: Celcuity’s Q1 2026 results beat expectations - Investing.com
Earnings call transcript: Celcuity’s Q1 2026 results beat expectations By Investing.com - Investing.com Canada
Transcript: Celcuity Q1 2026 Earnings Conference Call - Benzinga
Celcuity Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Celcuity Inc. (NASDAQ:CELC) Q1 Earnings Beat Forecasts, But Stock Drops on Phase 3 Data Focus - ChartMill
Celcuity posts narrower-than-feared Q1 loss By Investing.com - Investing.com South Africa
Celcuity Inc (CELC) 財務データ
収益
当期純利益
現金流量
EPS
Celcuity Inc (CELC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Buller Richard E | Director |
May 04 '26 |
Option Exercise |
5.10 |
9,000 |
45,900 |
15,760 |
| Buller Richard E | Director |
May 04 '26 |
Sale |
140.46 |
9,000 |
1,264,181 |
6,760 |
2.25%
0.46%
大文字化:
|
ボリューム (24 時間):